Clindamycin Phosphate-Adapalene-Benzoyl Peroxide Topical Gel 0.15%/3.1%/1.2%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Clindamycin Phosphate-Adapalene-Benzoyl Peroxide Topical Gel 0.15%/3.1%/1.2%, covering 2024-11-05 to 2024-11-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. [Phase 1]